Related Experiment Videos
Signalling targets for the development of cancer drugs
Anti-Cancer Drug Design
|December 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
PI-3-Kinase inhibitors in colorectal cancer.
Current cancer drug targets·2010
In vitro metabolism of [(3)H]2,6-dinitrotoluene by human and rat liver.
Toxicology in vitro : an international journal published in association with BIBRA·2010
Adenine and pyridine nucleotide concentrations and relationships to 2,6-dinitrotoluene metabolism in cultured rat liver slices.
Toxicology in vitro : an international journal published in association with BIBRA·2010
Guidelines for the welfare and use of animals in cancer research.
British journal of cancer·2010
A phase I study of the nitroimidazole hypoxia marker SR4554 using 19F magnetic resonance spectroscopy.
British journal of cancer·2009
Topoisomerase I/II selectivity among derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA).
Anti-cancer drug design·2002
The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design?
Anti-cancer drug design·2002
Photokilling of cultured tumour cells by the porphyrin derivative CF3.
Anti-cancer drug design·2002
Cyclohexylamino-demethoxy-hypocrellin B and photodynamic therapy decreases human cancer in vitro.
Anti-cancer drug design·2002
Synthesis and anticancer activity of nordihydroguaiaretic acid (NDGA) and analogues.
Anti-cancer drug design·2002